NIH Renews Support to 7 Sites Nationwide

Stem Cell Research Heart

From bench to bedside: NIH grant establishes cardiac clinical research center at UofL University of Louisville among 7 sites nationwide for Cardiac Cell Therapy Research Network To paraphrase Yogi Berra: It’s déjà vu all over again – with a twist. A University of Louisville researcher known for his prowess at winning competitive grants from the National Institutes of Health has won another one – his first for clinical research. During his 18-year tenure at UofL, Dr. Roberto Bolli has generated more than $100 million in grants for basic research from the NIH. Today, Bolli joined with University of Louisville President James R. Ramsey to announce a new NIH grant he has won for clinical research,…

Stem Cell Therapy After Heart Attack

AHA_Logo_in_Globe-prv

Delayed Stem Cell Therapy Following Heart Attack is Safe But Not Effective NIH-funded trial shows that therapy with bone-marrow derived cells does not improve heart function after six months; future clinical benefits still possible WASHINGTON, Nov. 14 — The U.S. Department of Health & Human Services’ National Institutes of Health issued the following news release: Stem cells obtained from bone marrow, known as BMCs, can be safely injected into people 2-3 weeks following a heart attack, reports a new clinical trial supported by the National, Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. However, while safe, the BMCs did not improve heart function six months after their administration. This study,…

Stem cells continue to show promise in MI patients

Henry_Tim T

Incremental updates from studies looking for new ways to take advantage of the body’s own cellular-regeneration processes hint that different cell-based approaches may one day help to improve angina symptoms and restore myocardial function. At CRT 2011, the Cardiovascular Research Technologies conference, director of research at the Minnesota Heart Institute (MHI), Dr Tim Henry, presented the latest data from a variety of ongoing efforts to use adult stem cells to grow new blood vessels or new myocardium. MHI is part of the Cardiovascular Cell Therapy Research Network funded by the National Heart, Lung, and Blood Institute (NHLBI).  Read More   Recommend on FacebookTell a friend

Repairing Your Heart: The Possibility of Cell Therapy (Part 1)

CCTRN 1

The first in a series of three videos that give information about what happens to the heart after a heart attack, including the likelihood of heart failure. These videos also provide information on some National Institutes of Health-sponsored clinical trials to find out if stem cells taken from a person’s own bone marrow can be placed into injured heart muscle to improve the heart’s function. Watch Video Recommend on FacebookTell a friend

Repairing Your Heart: The Possibility of Cell Therapy (Part 2)

CCTRN 2

The second in a series of three videos that give information about what happens to the heart after a heart attack, including the likelihood of heart failure. These videos also provide information on some National Institutes of Health-sponsored clinical trials to find out if stem cells taken from a person’s own bone marrow can be placed into injured heart muscle to improve the heart’s function. Watch Video Recommend on FacebookTell a friend

Repairing the Heart: The Possibility of Cell Therapy (Part 3)

CCTRN 3

The third in a series of three videos that give information about what happens to the heart after a heart attack, including the likelihood of heart failure. These videos also provide information on some National Institutes of Health-sponsored clinical trials to find out if stem cells taken from a person’s own bone marrow can be placed into injured heart muscle to improve the heart’s function. Watch Video   Recommend on FacebookTell a friend